News and Announcements
Prescient Therapeutics Share Purchase Plan Results
- Published November 18, 2015 3:48PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
18th November 2015, ASX Announcement
Cancer drug development Prescient Therapeutics Limited (ASX: PTX) has closed its Share Purchase Plan, with strong demand from existing and new investors.
Investors have subscribed for $1,201,500 in new shares, with the price per share to be based on a 20% discount to the 5 day volume weighted average price (VWAP) before the issue date of 23 November 2015.
A final price will be announced on the date of issue of the SPP shares.
PTX advises that the Company is only permitted to accept a maximum of 30% of its current issued capital. In the event that a scale back is required, applications are new shares will be scaled back proportionately
To read the full announcement, please click here.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
